Role of Wnt5b‐Ror1 signaling in the proliferation of pancreatic ductal adenocarcinoma cells

Abstract

AbstractPancreatic ductal adenocarcinoma (PDAC) is one of the most refractory cancers with the worst prognosis. Although several molecules are known to be associated with the progression of PDAC, the molecular mechanisms underlying the progression of PDAC remain largely elusive. The Ror‐family receptors, Ror1 and Ror2, which act as a receptor(s) for Wnt‐family ligands, particularly Wnt5a, are involved in the progression of various types of cancers. Here, we show that higher expression of Ror1 and Wnt5b, but not Ror2, are associated with poorer prognosis of PDAC patients, and that Ror1 and Wnt5b are expressed highly in a type of PDAC cell lines, PANC‐1 cells. Knockdown of either Ror1 or Wnt5b in PANC‐1 cells inhibited their proliferation significantly in vitro, and knockout of Ror1 in PANC‐1 cells resulted in a significant inhibition of tumor growth in vivo. Furthermore, we show that Wnt5b‐Ror1 signaling in PANC‐1 cells promotes their proliferation in a cell‐autonomous manner by modulating our experimental setting in vitro. Collectively, these findings indicate that Wnt5b‐Ror1 signaling might play an important role in the progression of some if not all of PDAC by promoting proliferation.